TERMINATION AND TRANSITION AGREEMENT by and betweenTermination and Transition Agreement • February 29th, 2016 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 29th, 2016 Company Industry JurisdictionThis Termination and Transition Agreement (this “Agreement”), dated as of October 1, 2015 (the “Agreement Date”), is made by and among BioMarin Pharmaceutical Inc., a Delaware corporation (“BioMarin”) and Ares Trading S.A., a corporation organized under the laws of Switzerland (“Merck Serono”). BioMarin and Merck Serono are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
TERMINATION AND TRANSITION AGREEMENT by and betweenTermination and Transition Agreement • February 29th, 2016 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 29th, 2016 Company Industry JurisdictionThis Amended and Restated Termination and Transition Agreement (this “Agreement”), dated as of December 23, 2015 and is effective as of October 1, 2015 (such effective date, the “Agreement Date”), is made by and among BioMarin Pharmaceutical Inc., a Delaware corporation (“BioMarin”) and Ares Trading S.A., a corporation organized under the laws of Switzerland (“Merck Serono”). BioMarin and Merck Serono are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”